Updated:
Med Innovation
Med Innovation is a Suzhou-based PE firm running early-stage health-tech venture capital across digital health, AI diagnostics, and healthcare services.
Overview
Med Innovation is a private equity firm based in Suzhou, China. It focuses on venture capital investments. The firm has a team of 5 employees.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Suzhou
Corporate office
Suzhou, China
Sector focus
Frequently asked questions
What is Med Innovation's investment strategy?
Med Innovation focuses on early-stage venture capital in China's healthcare technology sector, targeting seed, startup, and general venture-stage companies. The firm's mandate spans digital health platforms, AI-enabled diagnostics, and healthcare services, aligning with domestic policy priorities around med-tech self-sufficiency. The firm deploys capital through both direct equity positions and limited fund commitments, per the firm's stated investment posture.
Why is Med Innovation headquartered in Suzhou rather than Shanghai or Beijing?
Suzhou has emerged as China's most prolific biotech hub by volume of NASDAQ-listed life-sciences companies originating from a single mainland Chinese city. The Suzhou Industrial Park offers regulatory incentives, dedicated biotech infrastructure, and proximity to a dense population of startups operating in med-tech, diagnostics, and drug discovery. For a specialized early-stage health-tech fund, physical proximity to company formation is a sourcing and operational advantage.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: